S-1 plus oxaliplatin versus capecitabine plus oxaliplatin for first-line treatment of patients with metastatic colorectal cancer: a randomised, non-inferiority phase 3 trial
Hong, YS (Hong, Yong Sang), Lee, KW (Lee, Keun-Wook), Chung, IJ (Chung, Ik-Joo), Cho, SH (Cho, Sang-Hee), Lee, KH (Lee, Kyung Hee), Shin, SJ (Shin, Sang Joon), Kang, HJ (Kang, Hye Jin), Shin, DB (Shin, Dong Bok), 이재원, Park, YS (Park, Young Suk), Hong, YS (Hong, Yong Sang), Lee, KW (Lee, Keun-Wook), Chung, IJ (Chung, Ik-Joo), Cho, SH (Cho, Sang-Hee), Lee, KH (Lee, Kyung Hee), Shin, SJ (Shin, Sang Joon), Kang, HJ (Kang, Hye Jin), Shin, DB (Shin, Dong Bok), 이재원, Park, YS (Park, Young Suk)
LANCET ONCOLOGY, 201211